A San Francisco federal jury has awarded $26.7m to genetic testing company Illumina Inc. in a dispute related to patents for prenatal testing technology.
Illumina alleged that the previous and current versions of the Harmony noninvasive prenatal test from Ariosa Diagnostics Inc.violated multiple claims in two patents awarded to Verinata Health Inc.,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?